Clinical Trial Update: Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 open-label dose-escalation study assessing safety and efficacy of STP705 in adults with Basal Cell Carcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• STP705

Snippet

Sponsor: Sirnaomics | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED